Cargando…
Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program)
In proliferating cells, mTOR is active and promotes cell growth. When the cell cycle is arrested, then mTOR converts reversible arrest to senescence (geroconversion). Rapamycin and other rapalogs suppress geroconversion, maintaining quiescence instead. Here we showed that ATP-competitive kinase inhi...
Autores principales: | Leontieva, Olga V., Demidenko, Zoya N., Blagosklonny, Mikhail V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695114/ https://www.ncbi.nlm.nih.gov/pubmed/26177051 |
Ejemplares similares
-
S6K in geroconversion
por: Leontieva, Olga V, et al.
Publicado: (2013) -
Tumor promoter-induced cellular senescence: cell cycle arrest followed by geroconversion
por: Leontieva, Olga V., et al.
Publicado: (2014) -
Rapamycin, proliferation and geroconversion to senescence
por: Blagosklonny, Mikhail V.
Publicado: (2018) -
CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: Duration of cell cycle arrest and MTOR activity determine geroconversion
por: Leontieva, Olga V, et al.
Publicado: (2013) -
Quantifying pharmacologic suppression of cellular senescence:
prevention of cellular hypertrophy versus preservation of proliferative
potential
por: Demidenko, Zoya N., et al.
Publicado: (2009)